Overview of Dr. Abuhadra
Dr. Nour Abuhadra is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Weill Cornell Medical College in Qatar and has been in practice 1 year. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 89 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has more than 20 publications and over 150 citings.
Office
300 East 66th Street
Floors 1 - 4
New York, NY 10065
Education & Training
Cleveland Clinic FoundationResidency, Internal Medicine, 2015 - 2018
Weill Cornell Medical College in QatarClass of 2015
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2021 - 2026
NJ State Medical License 2021 - 2025
OH State Medical License 2015 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Susan Papizan Dolan Fellowship in Breast Oncology (Recognition of Research Excellence) University of Texas - MD Anderson Cancer Center, 2020
- ASCO Employees Conquer Cancer Foundation Merit Award American Society of Clinical Oncology, 2020
- Research Merit Award European Society Of Medical Oncology, 2020
- Join now to see all
Publications & Presentations
PubMed
- Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel.Megan H Trager, Alyce M Kuo, Stephen W Dusza, Vivian Park, Larisa Geskin
Archives of Dermatological Research. 2024-10-09 - The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review.Areen Abu Remilah, Bilal Krayim, Eitan Amir, Ariadna Tibau, Mark E Robson
Critical Reviews in Oncology/hematology. 2024-10-01 - ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.Sara P Myers, Varadan Sevilimedu, V Morgan Jones, Nour Abuhadra, Giacomo Montagna
Annals of Surgical Oncology. 2024-08-01
Journal Articles
- Impact of social media for the hematologist/oncologist.Abuhadra, N et al, Seminars in Hematology, 10/1/2017
Abstracts/Posters
- Prognostic impact of high stromal tumor-infiltrating lymphocytes (sTIL) in the absence of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in early stag...Abuhadra, N et al, ASCO 2020, Chicago, IL. USA, 5/31/2020
- The Immunomodulatory (IM) Signature Enhances Prediction of Pathologic Complete Response (pCR) to Neoadjuvant Therapy (NAT) in Triple Negative Breast Cancers (TNBC) wit...Abuhadra, N et al, ESMO Breast Conference (Oral Presentation), Madrid, Spain (Virtual due to COVID-19), 5/1/2020
- Serial TILs: Evaluating the role of mid-treatment tumor infiltrating lymphocytes (TIL) in predicting pathologic complete response (pCR) in early-stage triple negative ...Abuhadra, N et al, San Antonio Breast Cancer Symposium, Texas, USA, 12/8/2019
- Join now to see all
Research History
- Developing patient selection strategies for chemotherapy de-escalation in early-stage triple-negative breast cancer.2018 - 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
